While the markets have been filled with uncertainty, GOLD has been reaching new heights in 2025!
Geopolitical instability = Higher gold prices.
And there is one NASDAQ-listed American stock that has yet to break its price target!
Sign up now and get ready to have your MIND BLOWN!
This the 1 Gold stock that we have been watching since $5.00!!
UnitedHealth falls short of second quarter expectations and offers weak outlook for 2025
Written by The Associated Press. Published 7/29/2025.
UnitedHealth delivered disappointing second-quarter earnings and went conservative with its 2025 forecast as soaring medical costs continue to swamp insurers.
The health care giant said Tuesday expenses that have jumped beyond what it expected when it set coverage prices will continue to pressure its performance. But CEO Stephen Hemsley told analysts the company expects a return to "solid but moderate earnings growth" in 2026.
UnitedHealth now expects adjusted earnings of at least $16 per share in 2025 after withdrawing its previous forecast in May. It had started 2025 with expectations of making up to $30 per share.
For the full year, analysts forecast earnings of $20.64 per share, according to the data firm FactSet.
UnitedHealth Group Inc. runs one of the nation's largest health insurance and pharmacy benefits management businesses. The Eden Prairie, Minnesota, company also operates a growing Optum business that provides care and technology support.
In May, the company withdrew its 2025 forecast due to higher-than-expected medical costs, and CEO Andrew Witty departed the company abruptly. He was replaced by Chairman Stephen Hemsley, who was the UnitedHealth CEO for more than a decade until 2017.
That came after the company took the rare step in April of cutting its forecast. That pushed UnitedHealth shares down $130 in their worst single-day performance in over 25 years.
Hemsley promised in June that UnitedHealth would establish a "prudent" 2025 earnings outlook when it detailed second-quarter results. He said Tuesday that the company had made operational mistakes and errors in setting its pricing for this year, but those problems were getting "needed attention."
Company leaders noted, for instance, that they expected costs to grow 5% for its Medicare Advantage business, and they have actually advanced more than 7%.
Several other insurers have said this month that they also have been hit by medical costs that are growing faster than expected. Companies have seen a rise in expensive emergency rooms visits, and UnitedHealth leaders said Tuesday that doctors are billing for more tests and services during those visits than they anticipated.
Insurers also are dealing with growing prescription drug costs, especially from expensive treatments for cancer and obesity, as well as gene therapy.
In the second quarter, UnitedHealth reported adjusted earnings of $4.08 per share on $111.6 billion in total revenue. Analysts expected earnings of $4.48 per share on $111.5 billion in revenue, according to FactSet.
The company's profit fell 19% to $3.41 billion even as revenue rose 13%. Medical costs, the company's biggest operating expense, jumped 20% to $78.6 billion in the quarter.
UnitedHealth shares dropped 4% Tuesday to $270.
That price topped $630 last November to reach a new all-time high. But the stock has mostly shed value since December, when UnitedHealthcare CEO Brian Thompson was fatally shot in midtown Manhattan on his way to the company's annual investor meeting.
Shares were already down 44% so far this year as of Monday. The Dow Jones Industrial Average, of which UnitedHealth is a member, had climbed 5%.
This message is a sponsored email sent on behalf of Huge Alerts, a third-party advertiser of MarketBeat. Why was I sent this email?.
This message is a paid advertisement for US Gold Corp (NASDAQ: USAU) from Huge Alerts and Sideways Frequency. MarketBeat Media, LLC receives a fixed fee for each subscriber that clicks on a link in this email, totaling up to $8,000. Other than the compensation received for this advertisement sent to subscribers, MarketBeat and its principals are not affiliated with either Huge Alerts or Sideways Frequency. MarketBeat and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither MarketBeat nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from MarketBeat to buy or sell any security. MarketBeat has not evaluated the accuracy of any claims made in this advertisement. MarketBeat recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding US Gold Corp (NASDAQ: USAU) on Sideways Frequency' website for additional information about the relationship between Sideways Frequency and US Gold Corp (NASDAQ: USAU).
If you have questions about your newsletter, please feel free to email MarketBeat's U.S. based support team at contact@marketbeat.com.
If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here.
© 2006-2025 MarketBeat Media, LLC. All rights reserved.
345 N Reid Place, Sixth Floor, Sioux Falls, South Dakota 57103. U.S.A..
0 Response to "1 Overlooked Gold Stock the Street Is Missing"
Post a Comment